The Current Ratio as of November 2024 (TTM) for TRACON Pharmaceuticals, Inc. (TCON) is 0.66

According to TRACON Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.66. This represents a change of -14.18% compared to the average of 0.77 of the last 4 quarters.

TRACON Pharmaceuticals, Inc. (TCON) Historical Current Ratio (quarterly & annually)

How has TCON Current Ratio performed in the past?

The mean historical Current Ratio of TRACON Pharmaceuticals, Inc. over the last ten years is 2.55. The current 0.66 Current Ratio has changed 2.48% with respect to the historical average. Over the past ten years (40 quarters), TCON's Current Ratio was at its highest in in the June 2015 quarter at 6.01. The Current Ratio was at its lowest in in the June 2023 quarter at 0.41.

TRACON Pharmaceuticals, Inc. (TCON) Current Ratio by Quarter and Year

Discovering the peaks and valleys of TRACON Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TRACON Pharmaceuticals, Inc. (TCON) Average Current Ratio

How has TCON Current Ratio performed in the past?

The current Current Ratio of TRACON Pharmaceuticals, Inc. (TCON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TRACON Pharmaceuticals, Inc. (TCON) Current Ratio vs. Peers

How is TCON’s Current Ratio compared to its peers?

TRACON Pharmaceuticals, Inc.’s Current Ratio is less than Rezolute, Inc. (13.79), less than XOMA Corporation (7.52), less than Sio Gene Therapies Inc. (5.52), less than Vincerx Pharma, Inc. (2.17), less than Histogen Inc. (4.05), less than Entera Bio Ltd. (6.61), less than Tempest Therapeutics, Inc. (1.69), greater than Better Therapeutics, Inc. (0.57), less than AN2 Therapeutics, Inc. (9.75), less than Miromatrix Medical Inc. (3.46), less than Inhibikase Therapeutics, Inc. (0.85), less than PMV Pharmaceuticals, Inc. (13.98), less than Anebulo Pharmaceuticals, Inc. (3.45), less than Candel Therapeutics, Inc. (1.18), less than Acurx Pharmaceuticals, Inc. (1.74), less than Monopar Therapeutics Inc. (5.41K), greater than Enochian Biosciences, Inc. (0.08), less than Kronos Bio, Inc. (8.32), less than Cyclerion Therapeutics, Inc. (5.07), less than Larimar Therapeutics, Inc. (13.10), less than Addex Therapeutics Ltd (4.97), less than Achilles Therapeutics plc (6.04),

Build a custom stock screener for TRACON Pharmaceuticals, Inc. (TCON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TRACON Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TRACON Pharmaceuticals, Inc. (TCON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TRACON Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.